---
title: "ZO Future Group Expects HK$178 Million Profit on Subsidiary Disposal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275448062.md"
datetime: "2026-02-10T11:27:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275448062.md)
  - [en](https://longbridge.com/en/news/275448062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275448062.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275448062.md) | [繁體中文](https://longbridge.com/zh-HK/news/275448062.md)


# ZO Future Group Expects HK$178 Million Profit on Subsidiary Disposal

ZO Future Group announced that it expects to record a profit attributable to owners of approximately HK$178.0 million for the six months ended 31 December 2025, compared to a loss of approximately HK$117.1 million for the same period in 2024. This significant turnaround in business performance is mainly due to a non-recurring gain of about HK$350.0 million arising from the disposal of a subsidiary. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZO Future Group published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260210-12020952), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ZO FUTURE GROUP (02309.HK)](https://longbridge.com/en/quote/02309.HK.md)

## Related News & Research

- [ZO Future Group Delays Circular on Subsidiary Disposal Pending Exchange Waiver](https://longbridge.com/en/news/273657976.md)
- [CICC Sticks to Their Buy Rating for Neusoft Education Technology Co. Limited (9616)](https://longbridge.com/en/news/281320027.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [China's detentions of Panama-flagged vessels raise concerns, Rubio says](https://longbridge.com/en/news/281541796.md)
- [Commodity wrap: Gold at 2-week high; oil below $100](https://longbridge.com/en/news/281404056.md)